Jean Peccoud | Source | Founder at GenoFAB, Inc.

Translating science into real-world applications has been my lifelong mission. As a synthetic biology pioneer, I’m dedicated to advancing model-driven approaches to develop life-changing products that save lives, feed the world, and drive sustainable growth.

I currently hold the Abell Chair in Synthetic Biology at Colorado State University, where I lead the Colorado Biofoundry, a cutting-edge facility focused on creating viral vectors and gene delivery systems for biomedical applications.

Over my career, I’ve authored over 100 peer-reviewed articles and served as the founding Editor-in-Chief of Synthetic Biology (Oxford University Press). I also sit on the editorial boards of Trends in Biotechnology and Nucleic Acids Research. Beyond academia, I’ve worked with federal agencies to anticipate and address emerging threats at the intersection of biology and computing, a field now known as cyberbiosecurity.

I founded GenoFAB to amplify the impact of my research by addressing unmet market needs in biotechnology. While publications and citations are valuable indicators of academic success, their true value lies in their ability to translate into products that solve real-world problems. GenoFAB bridges this gap by helping biotech companies and research organizations accelerate their programs through effective plasmid management.

Passionate about building bridges between science and engineering, and between industry and academia, I strive to create innovative R&D paradigms. If you’re looking to collaborate on new applications of synthetic biology, address cyberbiosecurity challenges, or accelerate life science research, let’s connect!